[Comment] National action for global gains in antimicrobial resistance
Few public health problems are of greater global importance today than antimicrobial resistance. Multidrug resistant pathogens are a challenge in high-income countries, and many countries, including the USA and the UK, have created national plans as well as legislation and regulation to address antibiotic resistance issues. However, middle-income and low-income countries are likely to bear the brunt of this problem. Many of our citizens do not have access to antibiotics. In the Lancet Series on antimicrobial access, sustainability, and effectiveness, Ramanan Laxminarayan and colleagues1 make the case that far more people die from lack of access to antibiotics than from antimicrobial resistance.